Critical conditions have yet to be met, Merck added. SpringWorks in late 2023 launched its first drug, Ogsiveo, a therapy for a rare type of tumors that occur in connective tissue known as desmoid ...
which causes tumors to grow in the tissue that covers nerves throughout the body. February 11, 2025 Germany's Merck in advanced talks to acquire US biotech firm SpringWorks Merck KGaA , the German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback